US equities |
META $623.87 ▼-1.06% TSLA $406.63 ▲+3.83% MU $932.67 ▲+3.21% NVDA $217.88 ▲+0.87% SPCX $150.13 ▲+2.20% AMD $559.19 ▲+5.25% SNDK $1,306.19 ▲+4.03% INTC $93.75 ▲+3.62%
FinancialContent

Articles published by ChemoCentryx, Inc.

News headline image
ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
From ChemoCentryx, Inc.
Via GlobeNewswire
Tickers CCXI
News headline image
ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From ChemoCentryx, Inc.
Via GlobeNewswire
Tickers CCXI